• NIA Innovations & COVID-19
  • Newsletter Sign-Up
  • FAQs
  • Case Studies
  • Contact Us
NIANIANIANIA
  • About
    • What the NIA offers
    • Selection Process
    • Core Team
    • Mentors
    • Partners
    • Collaborate
    • Apply
  • Fellows and Innovations
    • Overview
    • Fellows
    • Innovations
    • Alumni
  • Latest
    • Events
    • News & blogs

National Kidney Foundation announces new trial of Dip.io

    Home News National Kidney Foundation announces new trial of Dip.io
    NextPrevious

    National Kidney Foundation announces new trial of Dip.io

    By admin | News | Comments are Closed | 19 April, 2018 | 0

    America’s National Kidney Foundation (NKF) has announced the launch of a new clinical trial using NIA innovation Dip.io.

    The trial, using Dip.io’s smartphone app and urinalysis kit will provide important information on how to increase testing for chronic kidney disease (CKD) among patients with high blood pressure.

    Hypertension, or high blood pressure, is a contributing risk factor to CKD. One of the best ways to test for CKD and assess kidney damage is a simple urine test which detects the presence of albumin. Dip.io enables lay users to conduct a urinalysis test at home and securely share results with their clinicians.

    Approximately 30 million Americans have CKD, but nearly 90% do not know they have this condition. CKD progression can be slowed or halted if the disease, which often has no symptoms, is caught in its early stages.

    “Early detection of CKD is crucial so that risk factors can be aggressively managed to prevent end-stage renal disease and cardiovascular disease,” said Alexander Chang, M.D., practicing nephrologist and assistant professor in the Kidney Health Research Institute at Geisinger.

    Kerry Willis, Ph.D., Chief Scientific Officer, NKF, said: “Our hope is that a home-based test makes it easier for patients at risk for CKD to comply with regular albuminuria screening, and that this will lead to earlier diagnosis and treatment of CKD, reducing cardiovascular risk and preserving kidney function.

    The new trial will:

    • Examine the effect of mailed, Healthy.io smartphone urinalysis kits (Dip.io test) to improve albuminuria screening compliance and detection of albuminuria.
    • Examine the feasibility of pharmacists in improving management of detected albuminuria, as pharmacists will be instructed to confirm test with urine albumin/creatinine ratio and treat albuminuria.
    • Randomise 1,000 non-diabetic patients with hypertension who are receiving primary care at Geisinger. Patients will be randomized into two groups; one group receiving the usual care and one group who will receive a mailed Healthy.io urinalysis kit.
    • A home test will be mailed to 500 Geisinger patients who have been diagnosed with hypertension but who do not have diabetes, along with instructions for downloading the smartphone app, to determine if the patient also has CKD.
    • Geisinger patients will receive a letter and phone call educating them on the importance of screening for proteinuria from a team of nurses within the organization’s Care Gaps department. Appropriate follow-up will then be managed by the patient’s primary care provider and care team.

    “Healthy.io is proud to pioneer its ‘adherence as a service’ platform with such forward-looking institutions as Geisinger and the National Kidney Foundation,” said Yonatan Adiri, CEO of Healthy.io.

    “Our mission is to use advanced computer vision and patient centric design to let clinicians empower their patients at scale without additional cost or effort.”

    He added: “Like a Netflix for adherence we lean on the spread of digital technology and efficient logistics to offer on demand testing delivered directly to the home. With a smartphone in your pocket, the point of care becomes wherever you are.”

    The new clinical trial was announced NKF’s 2018 Annual Spring Clinical Meetings in Texas.

    For more information visit www.healthy.io

    No tags.

    Related Posts

    • Fibricheck announces new digital partnership to transform at-home AF detection and diagnosis

      By Morgan McKean | Comments are Closed

      Fibricheck, an NHS Innovation Accelerator innovation, recently announced s partnership with Daiichi Sankyo to improve the detection and diagnosis of Atrial Fibrillation (AF) at home. The collaboration supports the AHSN Network’s Detect, Protect and PerfectRead more

    • 2021 NHS Innovation Accelerator Fellows Announced!

      By Morgan McKean | Comments are Closed

      Twelve innovators selected to scale across England’s NHS with support from the NHS Innovation Accelerator Today, the NHS Innovation Accelerator (NIA) announces the 12 innovators (‘Fellows’) and innovations selected to join its award-winning programme inRead more

    • Now recruiting: Patient/Carer representative

      By Morgan McKean | Comments are Closed

      The NIA is currently recruiting for a patient and/or carer representative to join our Programme Board. In this role, you will oversee the delivery of the NIA programme and help ensure, with the rest ofRead more

    • World-first ADHD remote testing tool for clinicians launched in response to COVID crisis

      By Morgan McKean | 0 comment

      80% of the world’s healthcare professionals have reported that their patient’s mental health has worsened during the COVID-19 pandemic [i]. There is growing concern that ADHD care is compromised as patients have not been ableRead more

    • Now Hiring – Interim Deputy Director

      By Morgan McKean | 0 comment

      The NHS Innovation Accelerator is recruiting for an Interim Deputy Director on a 1-year fixed-term contract.   The Deputy Director will work with the National Director for the NIA to co-lead delivery of the acceleratorRead more

    NextPrevious
    Contact Us
    nia@uclpartners.com
    @NHSAccelerator
    Newsletter Sign-Up
    Terms and Conditions | Privacy and Cookies
    NHS Innovation Accerlator
    Copyright 2017 NHS Innovation Accelerator
    • Menu
      • Latest
      • Case Studies
      • News and Events
      • Press and Media
      • FAQs (OLD)
      • Contact Us
    • Apply
    • Fellows and Innovations
      • Fellows
      • Innovations
    • Collaborate
    • Accelerator
      • Partners
      • What the NIA offers
      • Selection Process
      • Mentors
    NIA